Literature DB >> 19542616

The neurodegenerative mitochondriopathies.

Russell H Swerdlow1.   

Abstract

Mitochondria are physically or functionally altered in many neurodegenerative diseases. This is the case for very rare neurodegenerative disorders as well as extremely common age-related ones such as Alzheimer's disease and Parkinson's disease. In some disorders very specific patterns of altered mitochondrial function or systemic mitochondrial dysfunction are demonstrable. Some disorders arise from mitochondrial DNA mutation, some from nuclear gene mutation, and for some the etiology is not definitively known. This review classifies neurodegenerative diseases using mitochondrial dysfunction as a unifying feature, and in doing so defines a group of disorders called the neurodegenerative mitochondriopathies. It discusses what mitochondrial abnormalities have been identified in various neurodegenerative diseases, what is currently known about the mitochondria-neurodegeneration nexus, and speculates on the significance of mitochondrial function in some disorders not classically thought of as mitochondriopathies.

Entities:  

Mesh:

Year:  2009        PMID: 19542616      PMCID: PMC2896000          DOI: 10.3233/JAD-2009-1095

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  176 in total

Review 1.  Neuronal degeneration and mitochondrial dysfunction.

Authors:  Eric A Schon; Giovanni Manfredi
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

2.  High frequency of mitochondrial complex I mutations in Parkinson's disease and aging.

Authors:  Rafal Smigrodzki; Janice Parks; W Davis Parker
Journal:  Neurobiol Aging       Date:  2004 Nov-Dec       Impact factor: 4.673

3.  A case of severe hypermetabolism of nonthyroid origin with a defect in the maintenance of mitochondrial respiratory control: a correlated clinical, biochemical, and morphological study.

Authors:  R LUFT; D IKKOS; G PALMIERI; L ERNSTER; B AFZELIUS
Journal:  J Clin Invest       Date:  1962-09       Impact factor: 14.808

4.  Decreased brain protein levels of cytochrome oxidase subunits in Alzheimer's disease and in hereditary spinocerebellar ataxia disorders: a nonspecific change?

Authors:  S J Kish; F Mastrogiacomo; M Guttman; Y Furukawa; J W Taanman; S Dozić; M Pandolfo; J Lamarche; L DiStefano; L J Chang
Journal:  J Neurochem       Date:  1999-02       Impact factor: 5.372

5.  Maternal inheritance in Parkinson's disease.

Authors:  G F Wooten; L J Currie; J P Bennett; M B Harrison; J M Trugman; W D Parker
Journal:  Ann Neurol       Date:  1997-02       Impact factor: 10.422

6.  Leber's optic atrophy: a possible example of vertical transmission of a slow virus in man.

Authors:  D C Wallace
Journal:  Australas Ann Med       Date:  1970-08

7.  Association of an extended haplotype in the tau gene with progressive supranuclear palsy.

Authors:  M Baker; I Litvan; H Houlden; J Adamson; D Dickson; J Perez-Tur; J Hardy; T Lynch; E Bigio; M Hutton
Journal:  Hum Mol Genet       Date:  1999-04       Impact factor: 6.150

8.  beta-Amyloid fragment 25-35 selectively decreases complex IV activity in isolated mitochondria.

Authors:  L Canevari; J B Clark; T E Bates
Journal:  FEBS Lett       Date:  1999-08-20       Impact factor: 4.124

Review 9.  Friedreich ataxia.

Authors:  Massimo Pandolfo
Journal:  Arch Neurol       Date:  2008-10

10.  Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines.

Authors:  Alexander V Panov; Claire-Anne Gutekunst; Blair R Leavitt; Michael R Hayden; James R Burke; Warren J Strittmatter; J Timothy Greenamyre
Journal:  Nat Neurosci       Date:  2002-08       Impact factor: 24.884

View more
  48 in total

1.  Decline in mitochondrial bioenergetics and shift to ketogenic profile in brain during reproductive senescence.

Authors:  Jia Yao; Ryan T Hamilton; Enrique Cadenas; Roberta Diaz Brinton
Journal:  Biochim Biophys Acta       Date:  2010-06-09

2.  Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease.

Authors:  Baiyang Sheng; Xinglong Wang; Bo Su; Hyoung-gon Lee; Gemma Casadesus; George Perry; Xiongwei Zhu
Journal:  J Neurochem       Date:  2011-12-08       Impact factor: 5.372

3.  Functional genomic analyses identify pathways dysregulated by progranulin deficiency, implicating Wnt signaling.

Authors:  Ezra Y Rosen; Eric M Wexler; Revital Versano; Giovanni Coppola; Fuying Gao; Kellen D Winden; Michael C Oldham; Lauren Herl Martens; Ping Zhou; Robert V Farese; Daniel H Geschwind
Journal:  Neuron       Date:  2011-09-21       Impact factor: 17.173

Review 4.  Estrogen: a master regulator of bioenergetic systems in the brain and body.

Authors:  Jamaica R Rettberg; Jia Yao; Roberta Diaz Brinton
Journal:  Front Neuroendocrinol       Date:  2013-08-29       Impact factor: 8.606

Review 5.  Alzheimer's disease pathologic cascades: who comes first, what drives what.

Authors:  Russell H Swerdlow
Journal:  Neurotox Res       Date:  2011-09-13       Impact factor: 3.911

Review 6.  The role of mitochondria in neurodegenerative diseases.

Authors:  Massimiliano Filosto; Mauro Scarpelli; Maria Sofia Cotelli; Valentina Vielmi; Alice Todeschini; Valeria Gregorelli; Paola Tonin; Giuliano Tomelleri; Alessandro Padovani
Journal:  J Neurol       Date:  2011-05-22       Impact factor: 4.849

Review 7.  Cognitive impairment, genomic instability and trace elements.

Authors:  A Meramat; N F Rajab; S Shahar; R Sharif
Journal:  J Nutr Health Aging       Date:  2015-01       Impact factor: 4.075

8.  DNA Damage, Copper and Lead Associates with Cognitive Function among Older Adults.

Authors:  A Meramat; N F Rajab; S Shahar; R A Sharif
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

9.  ALS spinal neurons show varied and reduced mtDNA gene copy numbers and increased mtDNA gene deletions.

Authors:  Paula M Keeney; James P Bennett
Journal:  Mol Neurodegener       Date:  2010-05-26       Impact factor: 14.195

10.  Mitochondrial dysfunction in the striatum of aged chronic mouse model of Parkinson's disease.

Authors:  Gaurav Patki; Yi Che; Yuen-Sum Lau
Journal:  Front Aging Neurosci       Date:  2009-12-11       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.